Introduction
The classical triad of Sturge-Weber syndrome is a port-wine stain on the face, glaucoma and leptomeningeal angiomas. While Type I might include the whole triad, Type II presents with the involvement of the skin without leptomeningeal angiomas. Type III Sturge-Weber syndrome is the rarest subtype and presents with leptomeningeal involvement without the port-wine stain on the face (1) (2) (3) . Only a few cases of this type have been reported, and its incidence is unknown (4) (5) (6) (7) . This subtype is generally diagnosed based on the findings of leptomeningeal angiomas in contrast brain magnetic resonance imaging (MRI) scans and calcifications in the same region via brain computed tomography (CT) scans of patients presenting with seizures (4, 5) . Here, we present the case of a 5.5-month-old patient with Type III Sturge-Weber syndrome presenting with seizures.
Case Report
A 5.5-month-old male patient with age-appropriate mental and motor development was referred to our hospital with right sided partial seizures occurring several times a day. His physical examination and neurological examination were normal. The partial seizures were unresponsive to intravenous diazepam, diphenylhydantoin and midazolam. Intravenous levetiracetam was administered and the seizures were partially controlled. His electroencephalogram showed isolated sharp wave discharges in the temporal regions of the left hemisphere, and a slow back-ground rhythm of the left hemisphere compared to the right hemisphere ( Figure  1 ). Cranial MR imaging of the patient revealed pathological contrasts in the cortical regions involving the left hemisphere and in the leptomeningeal structures (Figure 2a ). Brain MR angiography and venography were normal. Lumber puncture was performed and serum samples were taken with the 
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Sturge-Weber syndrome (SWS) is a neurogenetic disease with an incidence of 1 in 20.000-50.000 live births. The less common form, which can be difficult to diagnose and only involves leptomeningeal angioma, has been defined as Type III SWS. A 5.5-month-old male patient with normal neuromotor development presented with right sided partial seizures, which had been occurring frequently for the previous two days and could not be controlled. A cranial magnetic resonance imaging showed pathological contrasts in the cortical regions involving the left hemisphere and in the leptomeningeal structures. We aim to present the case of an infant with SWS, which unlike the classical form was unidentifiable in physical examination and diagnosed using imaging methods. Keywords: Sturge-Weber, without nevus, epilepsy, children pre-diagnosis of meningoencephalitis. Intravenous acyclovir therapy was started. Biochemical and serological tests were normal. Repeated contrast brain MR imaging on the 7 th day indicated no change. Brain CT which was performed with the pre-diagnosis of Sturge-Weber syndrome revealed calcifications in the involved hemisphere ( Figure 2b ). The ophthalmological examination was normal, glaucoma was not determined. The patient's antiviral treatment was ceased and antiepileptic treatment was continued. The patient has been followed-up and diagnosed with Sturge-Weber syndrome Type III. His seizures are under control using diphenylhydantoin and levetiracetam. Informed family consent was taken from parents before publishing his diagnosis and treatment details.
Discussion
Sturge-Weber syndrome is a neurocutaneous disorder characterized by facial and leptomeningeal angiomas, glaucoma, hemiparesis, stroke-like attacks, seizures and also atrophy and calcifications in the brain. Abnormal intrauterine arterial and venous flow pattern, abnormal connections between deep and superficial veins, associated stasis and subsequent thrombosis and ischemia are blamed in the etiology (1). Type III Sturge-Weber syndrome is the rarest subtype and it is difficult to diagnose as it does not involve skin abnormalities. Similar to our patient, 75-90% of patients with this subtype present with seizures and receive diagnosis using imaging methods. While glaucoma is seen in approximately 30% of the patients with classical Sturge-Weber syndrome, it is often not seen in patients with Type III Sturge-Weber syndrome, which is attributed to the absence of facial angiomas. However, headache and migraine-like attacks are frequently seen (7, 8) . Atrophy, neuronal losses and astrogliosis can be seen in the brain tissue underlying the leptomeningeal angiomas, which may lead to structural impairments in the cortex. Proteins and Ca2 entering cells through increased vascular permeability cause a crystallization, which helps diagnosis. Gadoliniumenhanced T1-weighted imaging and susceptibility-weighted imaging performed at the early pre-symptomatic phase are useful in the detection of leptomeningeal angiomas (9) . Recently developed post contrast fluid-attenuated inversion recovery imaging and high-resolution blood oxygen level dependent MR venography may also increase sensitivity in detecting the leptomeningeal angioma (10) . In the presented case, although there was no other finding compatible with Sturge-Weber syndrome, the absence of other clinical clues for meningoencephalitis and no change in the radiological findings after antiviral therapy raised the suspicion for Sturge-Weber syndrome. Radiological findings are of great importance in the diagnosis of this subtype, since these patients do not present with dermatological symptoms. Leptomeningeal angiomas detected in patients can be confused with viral encephalitis and arteriovenous anomalies. Although cranial MRI is performed in most patients, this subtype is diagnosed via calcifications observed in cranial CT. It will be possible to establish a rapid and definitive diagnosis with the identification of genetic causes of the disorder. Sturge-Weber Type III can mimic different neurological diseases. Radiological findings are of great importance in the diagnosis of this subtype since these patients do not present with dermatological symptoms. Cranial CT and MR may be useful if the diagnosis is uncertain.
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